OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabis and COVID-19: Reasons for Concern
Margriet van Laar, Pieter E. Oomen, Charlotte J. A. van Miltenburg, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Alcohol and other substance use during the COVID-19 pandemic: A systematic review
Amanda Roberts, Jim Rogers, Rachael Mason, et al.
Drug and Alcohol Dependence (2021) Vol. 229, pp. 109150-109150
Open Access | Times Cited: 348

Cannabis‐related allergies: An international overview and consensus recommendations
Isabel Skypala, Samira Jeimy, Hannelore Brucker, et al.
Allergy (2022) Vol. 77, Iss. 7, pp. 2038-2052
Open Access | Times Cited: 51

A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic
Wendy Wing-Yee Chong, Zeynep Ilgaz Acar, Meghan Lee West, et al.
Cannabis and Cannabinoid Research (2022) Vol. 7, Iss. 5, pp. 591-602
Open Access | Times Cited: 43

Positive affect and reward processing in the treatment of depression, anxiety and trauma
Michelle G. Craske, Barnaby D. Dunn, Alicia E. Meuret, et al.
Nature Reviews Psychology (2024)
Closed Access | Times Cited: 15

Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
Inés Gallego‐Landin, Alba García-Baos, Adriana Castro‐Zavala, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 52

The Immunopathology of COVID-19 and the Cannabis Paradigm
Nicole Paland, Antonina Pechkovsky, Miran Aswad, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 42

Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services
Pieter E. Oomen, Dominique Schori, Karsten Tögel-Lins, et al.
International Journal of Drug Policy (2021) Vol. 100, pp. 103493-103493
Closed Access | Times Cited: 40

Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
Norbert Scherbaum, Udo Bonnet, Henning Hafermann, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 29

Changes in self-reported cannabis use during the COVID-19 pandemic: a scoping review
Kamna Mehra, Jennifer Rup, Jessica L. Wiese, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12

Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic
Ryan D. Assaf, Pamina M. Gorbach, Ziva D. Cooper
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 3, pp. 321-327
Open Access | Times Cited: 18

Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
Christopher N. Andrews, Renata Rehak, Matthew Woo, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 11-12, pp. 1532-1542
Closed Access | Times Cited: 17

Representative national survey on drug use during the COVID-19 stay-at-home order in the USA
Soo‐Hoon Lee, Bernadette Cullen, Alison Athey, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e086141-e086141
Open Access

Trends in cannabis use among U.S. adults amid the COVID-19 pandemic
Savannah G. Brenneke, Courtney Nordeck, Kira E. Riehm, et al.
International Journal of Drug Policy (2021) Vol. 100, pp. 103517-103517
Open Access | Times Cited: 23

The COVID-19 pandemic and cannabis use in Canada―a scoping review
Kelda Newport, Lisa Bishop, Jennifer Donnan, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 9

Increases in Alcohol and Cannabis Use Associated with Deteriorating Mental Health among LGBTQ2+ Adults in the Context of COVID-19: A Repeated Cross-Sectional Study in Canada, 2020–2021
Trevor Goodyear, Allie Slemon, Chris G. Richardson, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 22, pp. 12155-12155
Open Access | Times Cited: 18

Characteristics of adults with a medical cannabis license, reasons for use, and perceptions of benefit following medical cannabis legalization in Oklahoma
Darla E. Kendzor, Sarah J. Ehlke, Laili Kharazi Boozary, et al.
Preventive Medicine Reports (2022) Vol. 27, pp. 101777-101777
Open Access | Times Cited: 12

Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States
Stephanie Lake, Ryan D. Assaf, Pamina M. Gorbach, et al.
Cannabis and Cannabinoid Research (2022) Vol. 8, Iss. 1, pp. 174-183
Open Access | Times Cited: 11

Gender differences in cannabis use disorder symptoms: A network analysis
Emese Kroon, Alessandra C. Mansueto, Lauren Kuhns, et al.
Drug and Alcohol Dependence (2022) Vol. 243, pp. 109733-109733
Open Access | Times Cited: 11

COVID-19’s Impact on Substance Use and Well-Being of Younger Adult Cannabis Users in California: A Mixed Methods Inquiry
Ekaterina V. Fedorova, Carolyn F. Wong, Bridgid M. Conn, et al.
Journal of Drug Issues (2021) Vol. 52, Iss. 2, pp. 207-224
Open Access | Times Cited: 13

Changes in Substance Use Among People Seeking Alcohol and Other Drug Treatment During the COVID-19 Pandemic: Evaluating Mental Health Outcomes and Resilience
Molly Carlyle, Janni Leung, Zoe Walter, et al.
Substance Abuse Research and Treatment (2021) Vol. 15
Open Access | Times Cited: 13

Incidence rate and distinctive characteristics of first episode psychosis during the COVID-19 pandemic: a multicenter observational study
Francesc Roma i Casanovas, Amira Trabsa, Daniel Bergé, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10

Psychosocial factors associated with the risk of developing psychosis in a Mexican general population sample
Tecelli Domínguez‐Martínez, Tamara Sheinbaum, Ana Frésan, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top